Abstract:
The present invention relates to a composition for treating an ocular inflammatory disease, comprising hydrophilic sulfasalazine and hyaluronic acid, and a preparation method therefor. Furthermore, the present invention relates to a method for treating an ocular inflammatory disease, which comprises administering, to an individual, a therapeutically effective amount of hydrophilic sulfasalazine and hyaluronic acid.
Abstract:
The present invention relates to a transportation apparatus for patients, which is a transportation apparatus that transfers and moves a patient that is on a main body frame in which the legs thereof are mounted with moving wheels. The present invention includes: a sliding plate that is moved to slide to both sides along the widthwise direction, by a sliding and moving means, on the upper surface of the main body frame; a transport conveyor that is coupled to the upper portion of the sliding plate so as to be moved to slide with the sliding plate, and has a conveyor belt which rotate in the forward direction or reverse direction by a rotating and moving means, after the movement; and an operation unit that is disposed on the front surface of the main body frame in the lengthwise direction so as to operate the sliding plate and the transport conveyor by means of the sliding and moving means and the rotating and moving means. According to the present invention, polytrauma patients, spinalized patients, or the like can be transported swiftly, safely, and conveniently.
Abstract:
A method for tracking a user's gaze point using a mobile terminal is provided. The method includes detecting the user's eye area from a camera that is mounted in the mobile terminal and selecting reference points of the eye area, detecting a pupil corresponding to an interest area that is obtained from the reference points, generating a first virtual grid of the eye area using a pickup image of a gaze point of the pupil corresponding to each corner of the display and generating a second virtual grid having the same division areas as those of the first virtual grid in the display, and mapping a position of the pupil within the second virtual grid area corresponding to a position of the pupil within the first virtual grid.
Abstract:
The present invention relates to a pharmaceutical composition for treating and/or preventing arthritis, which comprising, as an active ingredient, a gene delivery vehicle into which an IK factor or a fragment thereof, or a nucleic acid encoding thereof is inserted. IK factor or the fragment thereof, and the nucleic acid encoding thereof, which are the active ingredient of the pharmaceutical composition according to the present invention, are derived from an organism and therefore, show no side effects in administered into a subject for a long time. Accordingly, they ensures safety and are expected to effectively treat arthritis by being involved in the upstream mechanism for suppressing arthritis.
Abstract:
The present invention relates to an apparatus for creating a tactile sensation through non-invasive brain stimulation by using ultrasonic waves. The apparatus includes: an ultrasonic transducer module for inputting the ultrasonic waves to stimulate a specific part of the brain of a specified user non-invasively through at least one ultrasonic transducer unit; a compensating module for acquiring information on a range of tactile perception areas in the brain of the specified user and compensating properties of ultrasonic waves to be inputted to the specified user through the ultrasonic transducer unit by referring to the acquired information thereon; and an ultrasonic waves generating module for generating ultrasonic waves to be inputted to the specified user through the ultrasonic transducer unit by referring to a compensating value decided by the compensating module.
Abstract:
The present invention relates to a use of mutant haptoglobin having angiogenesis-promoting activity and, more particularly, to a mutant haptoglobin polypeptide, a recombinant vector containing a polynucleotide encoding the polypeptide, or a composition for promoting angiogenesis containing, as an active ingredient, a transformant transformed with the recombinant vector. The mutant haptoglobin according to the present invention includes an amino acid sequence of SEQ ID NO: 1 in which the 143rd amino acid is substituted with an amino acid other than Arg. The mutant haptoglobin according to the present invention has excellent angiogenesis-promoting activity and excellent capillary-like tube formation capability as compared with wild-type haptoglobin, and promotes cell migration, and thus is useful as a therapeutic agent for treating diseases caused by non-angiogenesis.
Abstract translation:本发明涉及具有血管生成促进活性的突变型触珠蛋白的用途,更具体地说,涉及突变型触珠蛋白多肽,含有编码该多肽的多核苷酸的重组载体,或用于促进血管生成的组合物,其含有作为活性成分的 转化体用重组载体转化。 根据本发明的突变型触珠蛋白包含SEQ ID NO:1的氨基酸序列,其中第143位氨基酸被除Arg以外的氨基酸取代。 与野生型触珠蛋白相比,本发明的突变型触珠蛋白具有优异的血管生成促进活性和优异的毛细管样管形成能力,促进细胞迁移,因此可用作治疗由非 - 血管生成。
Abstract:
The method for extracting salient object from stereoscopic video includes: dividing regions based on the similarity of color and the distance between pixels in a left-eye image and a right-eye image which are used for an input stereoscopic image; creating a disparity map based on a disparity obtained from a pixel difference of the left-eye image and the right-eye image; calculating a contrast-based saliency by comparing the divided regions and the divided regions of the disparity map; calculating a prior-knowledge-based saliency based on a prior-knowledge for the divided regions and the divided regions of the disparity map; and extracting salient regions of the image based on the contrast-based saliency and the prior-knowledge-based saliency.
Abstract:
The invention relates to a composition for angiogenesis inhibition comprising a peroxidasin inhibitor as an effective ingredient, and more particularly, to a method of screening angiogenesis inhibitor, which includes steps of treating a test agent, and analyzing peroxidasin gene expression or protein activity, and comparing peroxidasin gene expression or protein activity between a case treated with the test agent and a case not treated with the test agent. Accordingly, since the inhibitor of the peroxidasin expression or protein activity according to the present invention can effectively inhibit migration, proliferation and tube formation of endothelial cells, the inhibitor can be effectively used for preventing or treating a variety of diseases or conditions of the diseases derived from abnormal regulation of angiogenesis.
Abstract:
The invention relates to a stereovision optometry apparatus comprising: a 3D display unit for displaying 3D image; a reference 2D display unit for displaying reference 2D image; an eyepiece in opposite side of the 2D display unit configured to view the images; a reflective mirror in opposite side of the 3D display unit configured to move toward and away from the 3D display unit; and a half mirror arranged between the 3D display and the reflective mirror and disposed at a point where propagation paths of the 2D image and the 3D image intersect; wherein the 2D image penetrates through the half mirror to reach the eyepiece; wherein the 3D image penetrates the half mirror to be reflected on the reflective mirror and then the reflected image is reflected on the half mirror to reach the eyepiece.
Abstract:
A method for tracking a user's gaze point using a mobile terminal is provided. The method includes detecting the user's eye area from a camera that is mounted in the mobile terminal and selecting reference points of the eye area, detecting a pupil corresponding to an interest area that is obtained from the reference points, generating a first virtual grid of the eye area using a pickup image of a gaze point of the pupil corresponding to each corner of the display and generating a second virtual grid having the same division areas as those of the first virtual grid in the display, and mapping a position of the pupil within the second virtual grid area corresponding to a position of the pupil within the first virtual grid.